Anti-citrullinated Protein Antibody-positive Rheumatoid Arthritis Associated with RS3PE Syndrome-like Symptoms and an Elevated Serum Vascular Endothelial Growth Factor Level in a Patient with Myasthenia Gravis

A 73-year-old man with a history of myasthenia gravis (MG) was diagnosed with rheumatoid arthritis (RA) based on a history of polyarthritis and positivity for anti-citrullinated protein antibodies (ACPA). He presented with a high level of serum vascular endothelial growth factor (VEGF) and RS3PE syn...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Internal Medicine 2014, Vol.53(8), pp.895-898
Hauptverfasser: Horai, Yoshiro, Honda, Mai, Nishino, Ayako, Nakashima, Yoshikazu, Suzuki, Takahisa, Kawashiri, Shin-ya, Ichinose, Kunihiro, Tamai, Mami, Nakamura, Hideki, Motomura, Masakatsu, Origuchi, Tomoki, Kawakami, Atsushi
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 898
container_issue 8
container_start_page 895
container_title Internal Medicine
container_volume 53
creator Horai, Yoshiro
Honda, Mai
Nishino, Ayako
Nakashima, Yoshikazu
Suzuki, Takahisa
Kawashiri, Shin-ya
Ichinose, Kunihiro
Tamai, Mami
Nakamura, Hideki
Motomura, Masakatsu
Origuchi, Tomoki
Kawakami, Atsushi
description A 73-year-old man with a history of myasthenia gravis (MG) was diagnosed with rheumatoid arthritis (RA) based on a history of polyarthritis and positivity for anti-citrullinated protein antibodies (ACPA). He presented with a high level of serum vascular endothelial growth factor (VEGF) and RS3PE syndrome-like pitting edema in the extremities, which improved following treatment with low-dose prednisolone. This is an interesting case of ACPA-positive RA associated with RS3PE syndrome-like pitting edema and a high VEGF level.
doi_str_mv 10.2169/internalmedicine.53.1897
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1622599884</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1517877642</sourcerecordid><originalsourceid>FETCH-LOGICAL-c603t-d9ac3d4302e11ef5a4b798b4d4dd49acc6fa014831846170e5b146847ff8d0873</originalsourceid><addsrcrecordid>eNqFkcFuEzEQhlcIRNPCKyAfuWxYr7273mNUpS1SClEDXFcTe5a4eO1ge1PlMXkjnCbkgJA4eKzxfP8_lv4sI7SYlrRuP2gb0VswAyottcVpxaZUtM2LbEIZb_OmZNXLbFK0VORlKhfZZQiPRcFE05avs4uSN6ytKZ9kv2Y26lzq6EdjtIWIiiy9i6gtOYzWTu3zrQs66h2Shw2OA0SnFZn5uPHpNZBZCE7qZ-WTjhvysGLLOVntrfJuwNzoH5i6YRvdEAhYlQ6ZG9w9K1box4F8gyBHA57MrXJxg0aDIbfePSW7G5DRebLAHRqSfgVkCVGjjcdt93sISWE1JAHsdHiTverBBHx7uq-yrzfzL9d3-eLz7cfr2SKXdcFirlqQTHFWlEgp9hXwddOKNVdcKZ5msu6hoFwwKnhNmwKrNeW14E3fC1WIhl1l74--W-9-jhhiN-gg0Riw6MbQ0bosq7YVgv8frWgjmqbmZULFEZXeheCx77ZeD-D3HS26Q_bd39l3FesO2Sfpu9OWcZ2GZ-GfsBPw6Qg8hgjf8QyAj1oa_KezOJTThjMoN-A7tOw39P_R4Q</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1517877642</pqid></control><display><type>article</type><title>Anti-citrullinated Protein Antibody-positive Rheumatoid Arthritis Associated with RS3PE Syndrome-like Symptoms and an Elevated Serum Vascular Endothelial Growth Factor Level in a Patient with Myasthenia Gravis</title><source>MEDLINE</source><source>J-STAGE (Japan Science &amp; Technology Information Aggregator, Electronic) Freely Available Titles - Japanese</source><creator>Horai, Yoshiro ; Honda, Mai ; Nishino, Ayako ; Nakashima, Yoshikazu ; Suzuki, Takahisa ; Kawashiri, Shin-ya ; Ichinose, Kunihiro ; Tamai, Mami ; Nakamura, Hideki ; Motomura, Masakatsu ; Origuchi, Tomoki ; Kawakami, Atsushi</creator><creatorcontrib>Horai, Yoshiro ; Honda, Mai ; Nishino, Ayako ; Nakashima, Yoshikazu ; Suzuki, Takahisa ; Kawashiri, Shin-ya ; Ichinose, Kunihiro ; Tamai, Mami ; Nakamura, Hideki ; Motomura, Masakatsu ; Origuchi, Tomoki ; Kawakami, Atsushi</creatorcontrib><description>A 73-year-old man with a history of myasthenia gravis (MG) was diagnosed with rheumatoid arthritis (RA) based on a history of polyarthritis and positivity for anti-citrullinated protein antibodies (ACPA). He presented with a high level of serum vascular endothelial growth factor (VEGF) and RS3PE syndrome-like pitting edema in the extremities, which improved following treatment with low-dose prednisolone. This is an interesting case of ACPA-positive RA associated with RS3PE syndrome-like pitting edema and a high VEGF level.</description><identifier>ISSN: 0918-2918</identifier><identifier>EISSN: 1349-7235</identifier><identifier>DOI: 10.2169/internalmedicine.53.1897</identifier><identifier>PMID: 24739614</identifier><language>eng</language><publisher>Japan: The Japanese Society of Internal Medicine</publisher><subject>Aged ; Arthritis, Rheumatoid - drug therapy ; Arthritis, Rheumatoid - epidemiology ; Arthritis, Rheumatoid - immunology ; Diagnosis, Differential ; Edema - diagnosis ; Edema - epidemiology ; Humans ; Male ; myasthenia gravis ; Myasthenia Gravis - epidemiology ; Prednisolone - therapeutic use ; rheumatoid arthritis ; RS3PE syndrome ; Syndrome ; Synovitis - diagnosis ; Synovitis - epidemiology ; vascular endothelial growth factor ; Vascular Endothelial Growth Factors - blood</subject><ispartof>Internal Medicine, 2014, Vol.53(8), pp.895-898</ispartof><rights>2014 by The Japanese Society of Internal Medicine</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c603t-d9ac3d4302e11ef5a4b798b4d4dd49acc6fa014831846170e5b146847ff8d0873</citedby><cites>FETCH-LOGICAL-c603t-d9ac3d4302e11ef5a4b798b4d4dd49acc6fa014831846170e5b146847ff8d0873</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,1883,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24739614$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Horai, Yoshiro</creatorcontrib><creatorcontrib>Honda, Mai</creatorcontrib><creatorcontrib>Nishino, Ayako</creatorcontrib><creatorcontrib>Nakashima, Yoshikazu</creatorcontrib><creatorcontrib>Suzuki, Takahisa</creatorcontrib><creatorcontrib>Kawashiri, Shin-ya</creatorcontrib><creatorcontrib>Ichinose, Kunihiro</creatorcontrib><creatorcontrib>Tamai, Mami</creatorcontrib><creatorcontrib>Nakamura, Hideki</creatorcontrib><creatorcontrib>Motomura, Masakatsu</creatorcontrib><creatorcontrib>Origuchi, Tomoki</creatorcontrib><creatorcontrib>Kawakami, Atsushi</creatorcontrib><title>Anti-citrullinated Protein Antibody-positive Rheumatoid Arthritis Associated with RS3PE Syndrome-like Symptoms and an Elevated Serum Vascular Endothelial Growth Factor Level in a Patient with Myasthenia Gravis</title><title>Internal Medicine</title><addtitle>Intern. Med.</addtitle><description>A 73-year-old man with a history of myasthenia gravis (MG) was diagnosed with rheumatoid arthritis (RA) based on a history of polyarthritis and positivity for anti-citrullinated protein antibodies (ACPA). He presented with a high level of serum vascular endothelial growth factor (VEGF) and RS3PE syndrome-like pitting edema in the extremities, which improved following treatment with low-dose prednisolone. This is an interesting case of ACPA-positive RA associated with RS3PE syndrome-like pitting edema and a high VEGF level.</description><subject>Aged</subject><subject>Arthritis, Rheumatoid - drug therapy</subject><subject>Arthritis, Rheumatoid - epidemiology</subject><subject>Arthritis, Rheumatoid - immunology</subject><subject>Diagnosis, Differential</subject><subject>Edema - diagnosis</subject><subject>Edema - epidemiology</subject><subject>Humans</subject><subject>Male</subject><subject>myasthenia gravis</subject><subject>Myasthenia Gravis - epidemiology</subject><subject>Prednisolone - therapeutic use</subject><subject>rheumatoid arthritis</subject><subject>RS3PE syndrome</subject><subject>Syndrome</subject><subject>Synovitis - diagnosis</subject><subject>Synovitis - epidemiology</subject><subject>vascular endothelial growth factor</subject><subject>Vascular Endothelial Growth Factors - blood</subject><issn>0918-2918</issn><issn>1349-7235</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkcFuEzEQhlcIRNPCKyAfuWxYr7273mNUpS1SClEDXFcTe5a4eO1ge1PlMXkjnCbkgJA4eKzxfP8_lv4sI7SYlrRuP2gb0VswAyottcVpxaZUtM2LbEIZb_OmZNXLbFK0VORlKhfZZQiPRcFE05avs4uSN6ytKZ9kv2Y26lzq6EdjtIWIiiy9i6gtOYzWTu3zrQs66h2Shw2OA0SnFZn5uPHpNZBZCE7qZ-WTjhvysGLLOVntrfJuwNzoH5i6YRvdEAhYlQ6ZG9w9K1box4F8gyBHA57MrXJxg0aDIbfePSW7G5DRebLAHRqSfgVkCVGjjcdt93sISWE1JAHsdHiTverBBHx7uq-yrzfzL9d3-eLz7cfr2SKXdcFirlqQTHFWlEgp9hXwddOKNVdcKZ5msu6hoFwwKnhNmwKrNeW14E3fC1WIhl1l74--W-9-jhhiN-gg0Riw6MbQ0bosq7YVgv8frWgjmqbmZULFEZXeheCx77ZeD-D3HS26Q_bd39l3FesO2Sfpu9OWcZ2GZ-GfsBPw6Qg8hgjf8QyAj1oa_KezOJTThjMoN-A7tOw39P_R4Q</recordid><startdate>20140101</startdate><enddate>20140101</enddate><creator>Horai, Yoshiro</creator><creator>Honda, Mai</creator><creator>Nishino, Ayako</creator><creator>Nakashima, Yoshikazu</creator><creator>Suzuki, Takahisa</creator><creator>Kawashiri, Shin-ya</creator><creator>Ichinose, Kunihiro</creator><creator>Tamai, Mami</creator><creator>Nakamura, Hideki</creator><creator>Motomura, Masakatsu</creator><creator>Origuchi, Tomoki</creator><creator>Kawakami, Atsushi</creator><general>The Japanese Society of Internal Medicine</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7TK</scope></search><sort><creationdate>20140101</creationdate><title>Anti-citrullinated Protein Antibody-positive Rheumatoid Arthritis Associated with RS3PE Syndrome-like Symptoms and an Elevated Serum Vascular Endothelial Growth Factor Level in a Patient with Myasthenia Gravis</title><author>Horai, Yoshiro ; Honda, Mai ; Nishino, Ayako ; Nakashima, Yoshikazu ; Suzuki, Takahisa ; Kawashiri, Shin-ya ; Ichinose, Kunihiro ; Tamai, Mami ; Nakamura, Hideki ; Motomura, Masakatsu ; Origuchi, Tomoki ; Kawakami, Atsushi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c603t-d9ac3d4302e11ef5a4b798b4d4dd49acc6fa014831846170e5b146847ff8d0873</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Aged</topic><topic>Arthritis, Rheumatoid - drug therapy</topic><topic>Arthritis, Rheumatoid - epidemiology</topic><topic>Arthritis, Rheumatoid - immunology</topic><topic>Diagnosis, Differential</topic><topic>Edema - diagnosis</topic><topic>Edema - epidemiology</topic><topic>Humans</topic><topic>Male</topic><topic>myasthenia gravis</topic><topic>Myasthenia Gravis - epidemiology</topic><topic>Prednisolone - therapeutic use</topic><topic>rheumatoid arthritis</topic><topic>RS3PE syndrome</topic><topic>Syndrome</topic><topic>Synovitis - diagnosis</topic><topic>Synovitis - epidemiology</topic><topic>vascular endothelial growth factor</topic><topic>Vascular Endothelial Growth Factors - blood</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Horai, Yoshiro</creatorcontrib><creatorcontrib>Honda, Mai</creatorcontrib><creatorcontrib>Nishino, Ayako</creatorcontrib><creatorcontrib>Nakashima, Yoshikazu</creatorcontrib><creatorcontrib>Suzuki, Takahisa</creatorcontrib><creatorcontrib>Kawashiri, Shin-ya</creatorcontrib><creatorcontrib>Ichinose, Kunihiro</creatorcontrib><creatorcontrib>Tamai, Mami</creatorcontrib><creatorcontrib>Nakamura, Hideki</creatorcontrib><creatorcontrib>Motomura, Masakatsu</creatorcontrib><creatorcontrib>Origuchi, Tomoki</creatorcontrib><creatorcontrib>Kawakami, Atsushi</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Neurosciences Abstracts</collection><jtitle>Internal Medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Horai, Yoshiro</au><au>Honda, Mai</au><au>Nishino, Ayako</au><au>Nakashima, Yoshikazu</au><au>Suzuki, Takahisa</au><au>Kawashiri, Shin-ya</au><au>Ichinose, Kunihiro</au><au>Tamai, Mami</au><au>Nakamura, Hideki</au><au>Motomura, Masakatsu</au><au>Origuchi, Tomoki</au><au>Kawakami, Atsushi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Anti-citrullinated Protein Antibody-positive Rheumatoid Arthritis Associated with RS3PE Syndrome-like Symptoms and an Elevated Serum Vascular Endothelial Growth Factor Level in a Patient with Myasthenia Gravis</atitle><jtitle>Internal Medicine</jtitle><addtitle>Intern. Med.</addtitle><date>2014-01-01</date><risdate>2014</risdate><volume>53</volume><issue>8</issue><spage>895</spage><epage>898</epage><pages>895-898</pages><issn>0918-2918</issn><eissn>1349-7235</eissn><abstract>A 73-year-old man with a history of myasthenia gravis (MG) was diagnosed with rheumatoid arthritis (RA) based on a history of polyarthritis and positivity for anti-citrullinated protein antibodies (ACPA). He presented with a high level of serum vascular endothelial growth factor (VEGF) and RS3PE syndrome-like pitting edema in the extremities, which improved following treatment with low-dose prednisolone. This is an interesting case of ACPA-positive RA associated with RS3PE syndrome-like pitting edema and a high VEGF level.</abstract><cop>Japan</cop><pub>The Japanese Society of Internal Medicine</pub><pmid>24739614</pmid><doi>10.2169/internalmedicine.53.1897</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0918-2918
ispartof Internal Medicine, 2014, Vol.53(8), pp.895-898
issn 0918-2918
1349-7235
language eng
recordid cdi_proquest_miscellaneous_1622599884
source MEDLINE; J-STAGE (Japan Science & Technology Information Aggregator, Electronic) Freely Available Titles - Japanese
subjects Aged
Arthritis, Rheumatoid - drug therapy
Arthritis, Rheumatoid - epidemiology
Arthritis, Rheumatoid - immunology
Diagnosis, Differential
Edema - diagnosis
Edema - epidemiology
Humans
Male
myasthenia gravis
Myasthenia Gravis - epidemiology
Prednisolone - therapeutic use
rheumatoid arthritis
RS3PE syndrome
Syndrome
Synovitis - diagnosis
Synovitis - epidemiology
vascular endothelial growth factor
Vascular Endothelial Growth Factors - blood
title Anti-citrullinated Protein Antibody-positive Rheumatoid Arthritis Associated with RS3PE Syndrome-like Symptoms and an Elevated Serum Vascular Endothelial Growth Factor Level in a Patient with Myasthenia Gravis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T01%3A23%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Anti-citrullinated%20Protein%20Antibody-positive%20Rheumatoid%20Arthritis%20Associated%20with%20RS3PE%20Syndrome-like%20Symptoms%20and%20an%20Elevated%20Serum%20Vascular%20Endothelial%20Growth%20Factor%20Level%20in%20a%20Patient%20with%20Myasthenia%20Gravis&rft.jtitle=Internal%20Medicine&rft.au=Horai,%20Yoshiro&rft.date=2014-01-01&rft.volume=53&rft.issue=8&rft.spage=895&rft.epage=898&rft.pages=895-898&rft.issn=0918-2918&rft.eissn=1349-7235&rft_id=info:doi/10.2169/internalmedicine.53.1897&rft_dat=%3Cproquest_cross%3E1517877642%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1517877642&rft_id=info:pmid/24739614&rfr_iscdi=true